Skip to main content

Share story

Policy

State Regulation of AI in Health Care

State Regulation of AI in Health Care Image: Primary
Texas and California recently imposed healthcare-focused regulations that restrict the use of artificial intelligence in medical necessity determinations and mandate significant human oversight in clinical decision-making processes, according to a blog post by Morgan Lewis. The regulations come as state legislatures scramble to pass AI enforcement laws grounded in consumer protection, antitrust, and false claims statutes. Several states have also established notice and consent requirements for recording communications, mandating that licensed professionals supply notice and obtain verbal and written consent prior to utilizing AI tools to record conversations, according to the National Law Review. The Department of Justice has appeared inclined to apply tenets of the False Claims Act toward adjudicating the deployment of AI tools in healthcare reimbursement activity, according to a Morgan Lewis blog post. Jeff Wurzburg, healthcare partner at Norton Rose Fulbright, recently told Healthcare IT News that the use of AI does not shift liability away from providers or health plans submitting claims to federal healthcare programs. He said large-scale automation raises the risk of systemic errors such as embedded upcoding, inappropriate denials, or algorithmic bias toward revenue optimization. The Centers for Medicare & Medicaid Services, Health and Human Services Office of Inspector General, and the Department of Justice are projected to implement longstanding fraud and abuse laws in their oversight efforts, according to Healthcare IT News.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Compliance Week and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital Products
Capital Products

ID Finance announces €545 million in funding to expand Plazo

Barcelona-based ID Finance announced €545 million in debt and equity funding to expand its consumer finance app Plazo. Participants included Spice Expeditions, WashU, Kingsway Capital and i80 Group, which provided asset-based fina...

Capital
Capital

Undecimal Bio raises €16 million for targeted RNA delivery

Cambridge-based Undecimal Bio announced €16 million ($18 million) in seed financing to expand its platform for delivering RNA medicines to specific cell types. 4BIO Capital and IQ Capital co-led the round, which will also support ...

Capital AI
Capital AI

Clueso raises $10M for AI agents that produce corporate video

Clueso says it raised a $10M Series A led by Dharana Capital, bringing total funding to $12M. More than 80% of the new money came from existing investors increasing their stakes, according to the company. Its agents navigate soft...

Capital AI
Capital AI

CarbonFarm closes €7 million Series A for rice emissions technology

Paris-based CarbonFarm has closed an oversubscribed €7 million Series A led by Colam Impact to expand its rice decarbonisation business. Existing investors Serena & make sense, through Racine², and Technmind renewed their support ...

AI Products
AI Products

Character.AI files for Chapter 11 as platform faces possible shutdown

Character.AI has filed for Chapter 11 bankruptcy after lawsuits and difficulties scaling its chatbot platform, TechCrunch reported. A court document lists assets and liabilities between $50 million and $100 million. The company al...